Activation of the AKT/mTOR signaling pathway through mutation of pathway components as well as through activation of upstream signaling molecules occurs in a majority of cancers and contributes to deregulation of proliferation and resistance to apoptosis [6, 7]. This evidence concerns the gene AKT1 and cancer.